Multiplicity of glucocorticoid action in inhibiting allograft rejection

Cell Transplantation

Volumn 7, Issue 6, 1998, Pages 511-523

  Almawi, Wassim Y ^a,c   Hess, David A ^b   Rieder, Michael J ^b  

^a NATIONAL COUNCIL FOR SCIENTIFIC RESEARCH   (Lebanon)

^b CHILDREN S HOSPITAL OF WESTERN ONTARIO   (Canada)

^c SAINT GEORGE HOSPITAL UNIVERSITY MEDICAL CENTER   (Lebanon)

Author keywords

Cytokines; Glucocorticoids; mRNA; T Cells; Transplantation

Indexed keywords

ARACHIDONIC ACID; CELL ADHESION MOLECULE; CYTOKINE; CYTOSOL RECEPTOR; GLUCOCORTICOID; LIPOCORTIN; TRANSFORMING GROWTH FACTOR BETA;

ALLOGRAFT; CYTOKINE PRODUCTION; DNA BINDING; GENE EXPRESSION; GENE EXPRESSION REGULATION; GRAFT REJECTION; HELPER CELL; IMMUNOLOGICAL TOLERANCE; ORGAN TRANSPLANTATION; PLEIOTROPY; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; GLUCOCORTICOIDS; GRAFT REJECTION; HUMANS; ORGAN TRANSPLANTATION; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 0031738222     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0963-6897(98)00042-6     Document Type: Review

References (199)

1. Akerblom, I.E.; Slater, E.P.; Beato, M.; Baxter, J.D.; Mellon, P.L. Negative regulation by glucocorticoids through intereference with a cAMP responsive enhancer. Science 241:350-353; 1988.
2. Almawi, W.Y.; Beyhum, H.N.; Rahme, A.A.; Rieder, M.J. Regulation of cytokine and cytokine receptor expression by glucocorticoids. J. Leukocyte Biol. 66:563-572; 1996.
3. Almawi, W.Y.; Hadro, E.T.; Strom, T.B. Evidence that glucocorticosteroid-mediated immunosuppressive effects do not involve altering second messenger function. Transplantation 52:133-140; 1991.
4. Almawi, W.Y.; Lipman, M.L.; Stevens, A.C.; Zanker, B.; Hadro, E.T.; Strom, T.B. Abrogation of glucocorticoisteroid-mediated inhibition of T cell proliferation by the synergistic action of IL-1, IL-6, and IFN-gamma. J. Immunol. 146:3523-3527; 1991.
5. Almawi, W.Y.; Saouda, M.S.; Stevens, A.C.; Lipman, M.L.; Barth, C.M.; Strom, T.B. Partial mediation of glucocorticoid anti-proliferative effecte by lipocortins. J. Immunol. 156:3523-3529; 1996.
6. Almawi, W.Y.; Sewell, K.L.; Hadro, E.T.; Zanker, B.; Strom, T.B. Mode of action of the glucocorticosteroids as immunosuppressive agents. Prog. Leukocyte Biol. 10A: 321-326; 1990.
7. Almawi, W.Y.; Stevens, A.C.; Lipman, M.L. Immunosuppressive drugs acting through inhibition of cytokine expression. In: Oppenheim, J.J.; Russio, A.J.H.; Kluger, M., eds. Clinical applications of cytokines, role in pathogenesis, diagnosis and therapy. New York: Oxford University Press; 1993:269-273.
8. Amano, Y.; Lee, S.W.; Allison, A.C. Inhibition by glucocorticoids of the formation of interleukin-1α, interleukin-1β, and interleukin-6: Mediation by decreased mRNA stability. Mol. Pharmacol. 43:176-182; 1993.
9. Angel, P.; Karin, M. The role of Jun, Fos, and the AP-1 complex in cell proliferation and transformation. Biochem. Biophys. Acta 1072:129-134; 1991.
10. Antonakis, N.; Georgoulias, V.; Margioris, A.N.; Stournaras, C.; Gravanis, A. In vitro differential effects of the antiglucocorticoid RU486 on the release of lymphokines from mitogen-activated normal human lymphocytes. J. Steroid Biochem. Mol. Biol. 51:647-672; 1994.
11. Araneo, B.A.; Dowell, T.; Moon, T.; Daynes, R.A. Regulation of murine lymphokine production in vivo. Untraviolet radiation exposure depresses IL-2 and enhances IL-4 production by T cells through an IL-1-dependent mechanism. J. Immunol. 143:1737-1744; 1989.
12. Auphan, N.; Didonato, J.A.; Rosette, C.; Helmberg, A.; Karin, M. Immunosuppression by glucocorticoids: Inhibition of NF-κB activity through induction of IκB synthesis. Science 270:286-289; 1995.
13. Ayanlar-Batuman, O.; Ferrero, A.P.; Diaz, A.; Jimenez, S.A. Regulation of transforming growth factor-beta 1 gene expression by glucocorticoids in normal human T lymphocytes. J. Clin. Invest. 88:1574-1580; 1991.
14. Aziz, K.E.; Wakefield, D. Modulation of endothelial cell expression of ICAM-1, E-selectin, and VCAM-1 by beta-estradiol, progesterone, and dexamethasone. Cell. Immunol. 167:79-85; 1996.
15. Ban, E.; Marquette, C.; Sarrieau, A.; Fitzpatrick, F.; Fillion, G.; Milon, G.; Rostene, W.; Haour, F. Regulation of interleukin-1 receptor expression in mouse brain and pituitary by lipopolysaccharide and glucocorticoids. Neuroendocrinology 58: 581-587; 1993.
16. Batuman, O.A.; Ferrero, A.P.; Diaz, A.; Berger, B.; Pomerantz, R.J. Glucocorticoid-mediated inhibition of interleukin-2 receptor alpha and beta subunit expression by human T cells. Immunopharmacology 27:43-55; 1994.
17. Baus, M.; Andris, F.; Dubois, P.M.; Urbain, J.; Leo, O. Dexamethasone inhibits the early steps of antigen receptor signaling in activated T lymphocytes. J. Immunol. 156:4555-4561; 1996.
18. Berg, J.M. DNA binding specificity of steroid receptors. Cell 57:1065-1068; 1989.
19. Beyers, A.D.; Spruyt, L.L.; Williams, A.F. Molecular associations between the T-lymphocyte antigen receptor complex and the surface antigens CD2, CD4, or CD8 and CD5. Proc. Natl. Acad. Sci. USA 89:2945-2949; 1992.
20. Blank, V.; Kowilsky, P.; Israel, A. NF-κB and related proteins: Rel/dorsal homologies meet ankyrin-like repeats. Trends Biochem. Sci. 17:135-139; 1992.
21. Blotta, M.H.; DeKruyff, R.H.; Umetsu, D.T. Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes. J. Immunol. 158:5589-5595; 1997.
22. Boulanger, J.; Reyes-Moreno, C.; Koutsilieris, M. Mediation of glucocorticoid receptor function by the activation of latent transforming growth factor beta 1 in MG-63 human osteosarcoma cells. Int. J. Cancer 61:692-697; 1995.
23. Boumpas, D.T.; Anastassiou, E.D.; Older, S.A.; Tsokos, G.C.; Nelson, D.L.; Balow, J.E. Dexamethasone inhibits interlukin 2 but not interleukin 2 receptor gene expression in vitro at the level of nuclear transcription. J. Clin. Invest. 87:1739-1747; 1991.
24. Boumpas, D.T.; Chrousos, G.P.; Wilder, R.L.; Cupps, T.R.; Balow, J.E. Glucocorticoids therapy for immune-mediated diseases: Basic and clinical correlates. Ann. Intern. Med. 119:1198-1208; 1993.
25. Brabletz, T.; Pietrowski, I.; Serfling, E. The immunosuppressive FK506 and cyclosporin A inhibit the generation of protein factors binding to the two purine boxes of the interleukin 2 enhancer. Nucleic Acids Res. 19:61-67; 1991.
26. Brack, A.; Rittner, H.L.; Younge, B.R.; Kaltschmidt, C.; Weyand, C.M.; Goronzy, J.J. Glucocorticoid-mediated repression of cytokine gene transription in human arteritis-SCID chimeras. J. Clin. Invest. 99:2842-2850; 1997.
27. Byron, K.A.; Varigos, G.; Wooton, A. Hydrocortisone inhibition of human interleukin-4. Immunology 77:624-626; 1992.
28. Campbell, X.; Ianches, G.; Hamilton, J.A. Production of macrophage colony-stimulating factor (M-CSF) by human articular cartilage and chondrocytes. Modulation by interleukin-1 and tumor necrosis factor. Biochim. Biophys. Acta 1182:57-63; 1993.
29. Campos, S.P.; Wang, Y.; Koj, A.; Baumann, H. Divergent transforming growth factor-beta effects on IL-6 regulation of acute phase plasma proteins in rat hepatoma cells. J. Immunol. 151:7128-7137; 1993.
30. Cantrell, D. T cell antigen receptor signal transduction pathways. Annu. Rev. Immunol. 14:259-274; 1996.
31. Chambers, S.K.; Gilmore-Hebert, M.; Wang, Y.; Rodov, S.; Benz, E.J., Jr.; Kacinski, B.M. Posttranscriptional regulation of colony-stimulating factor-1 (CSF-1) and CSF-1 receptor gene expression during inhibition of phrobol ester-induced monocytic differentiation by dexamethasone and cyclosporin A: Potential involvement of a destabilizing protein. Exp. Hematol. 21:1328-1334; 1993.
32. Churchill, L.; Freidman, B.; Schleimer, R.P.; Proud, D. Production of granulocyte-macrophage colony-stimulating factor by cultured human tracheal epithelial cells. Immunology 75:189-195; 1992.
33. Clipstone, N.A.; Crabtree, G.R. Identification of calcineeurin as a key signaling enzyme in T lymphocyte activation. Nature 357:695-697; 1992.
34. Constant, S.; Pfeifer, C.; Woodard, A.; Pasqualini, T.; Bottomly, K. Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells. J. Exp. Med. 182:1591-1596; 1996.
35. Cronstein, B.N.; Kimmel, S.C.; Levin, R.I.; Martiniuk, F.; Weissmann, G. A mechanism for the anti-inflammatory effects of corticosteroids: The glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intracellular adhesion molecule 1. Proc. Natl. Acad. Sci. USA 89:9991-9995; 1992.
36. Croxtall, J.D.; Choudhury, Q.; Newman, S.; Flower, R.J. Lipocortin and the control of cPLA2 activity in A549 cells. Glucocorticoids block EGF stimulation of cPLA2 phosphorylation. Biochem. Pharmacol. 52:351-356; 1996.
37. Croxtall, J.D.; Choudhury, Q.; Tokumoto, H.; Flower, R.J. Lipocortin-1 and the control of arachidonic acid release in cell signalling. Glucocorticoids inhibit G proetin-dependent activation of cPLA2 activity. Biochem. Pharmacol. 50:465-474; 1995.
38. Croxtall, J.D.; Flower, R.J. Lipocortin 1 mediates dexamethasone-induced growth arrest of the A549 adenocarcinoma cell line. Proc. Natl. Acad. Sci. USA 89:3571-3575; 1992.
39. Croxtall, J.D.; Newman, S.P.; Choudhury, Q.; Flower, R.J. The concerted regulation of cPLA2, COX-2, and lipocortin expression by IL-1beta in A549 cells. Biochem. Biophys. Res. Commun. 220:491-495; 1996.
40. Culpepper, J.A.; Lee, F. Regulation of IL-3 expression by glucocorticoids in cloned murine T lymphocytes. J. Immunol. 135:3191-3195; 1985.
41. Culpepper, J.; Lee F. Glucocorticoids regulation of lymphokine production by murine T lymphocytes. Lymphokine 13:275-280; 19487.
42. Danielpour, D.; Kim, K.Y.; Winokur, T.S.; Sporn, M.B. Differential regulation of the expression of transforming growth factor-beta 1 and 2 by retinoic acid, epidermal growth factor, and dexamethasone in NRK-49F and A549 cells. J. Cell Physiol 148:235-244; 1991.
43. Daynes, R.A.; Araneo, B.A. Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4. Eur. J. Immunol. 19:2319-2325; 1989.
44. Daynes, R.A.; Araneo, B.A.; Dowell, T.A.; Huang, K.; Dudley, D. Regulation of murine lymphokine production in vivo. III. The lymphoid tissue micro-environment exerts regulatory influences over T helper cell function. J. Exp. Med. 171:979-996; 1990.
45. Dennis, G.; June, C.H.; Mizuguchi, J.; Ohara, J.; Witherspoon, K.; Finkelman, K.; McMillan, V.; Mond, J.J. Glucocorticoids suppress calcium mobilization and phospholipid hydrolysis in anti-Ig antibody-stimulated B cells. J. Immunol. 139:2516-2523; 1987.
46. Desai, D.M.; Newton, M.E.; Kadlecek, T.; Weiss, A. Stimulation of the phosphatidyl inositol pathway can induce T cell activation. Nature 348:66-69; 1990.
47. fyn are reduced by a glucocorticoid-dependent mechanism in graft-versus-host reaction-induced T cell anergy. Cell. Immunol. 163:10-18; 1995.
48. Diamond, M.I.; Miner, J.N.; Yoshinaga, S.K.; Yamamoto, K.R. Transcription factor interactions: Selectors of positive or negative regulation from a single DNA element. Science 249:1266-1272; 1990.
49. DiLorenzo, D.; Williams, P.; Ringold, G. Identification of two distinct nuclear factors with DNA binding activity within the glucocorticoid regulatory region of the rat alpha-1-acid glycoprotein promoter. Biochem. Biophys. Res. Commun. 176:1326-1332; 1991.
50. Drouin, J.; Sun, Y.L.; Tremblay, S.; Lavender, P.; Schmidt, T.J.; de Lean, A.; Nemer, M. Homodimer formation is rate-limiting for high-affinity DNA binding by glucocorticoid receptor. Mol. Endocrinol. 6:1299-1309; 1992.
51. Dubois, C.M.; Neta, R.; Keller, R.J.; Jacobsen, S.E.W.; Oppenheim, J.J.; Ruscetti, F. Hematopoietic growth factors and glucocorticoids synergize to mimic the effects of IL-1 on granulocyte differentiation and IL-1 receptor induction on bone marrow cells in vivo. Exp. Hematol. 21:303-310; 1993.
52. Elder, R.T.; Xu, X.; Williams, J.W.; Gong, H.; Finnegan, A.; Chong, A.S.-F. The immunosuppressive metabolite of leflunomide, A77 1726, affects murine T cells through two biochemical mechanisms. J. Immunol. 159:22-27; 1997.
53. Elenkov, I.J.; Papanicolaou, D.A.; Wilder, R.L.; Chrousos, G.P. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proc. Assoc. Am. Phys. 108:374-381; 1996.
54. Eguchi, K.; Kawakami, A.; Nakashima, M.; Ida, H.; Sakito, S.; Matsuoka, N.; Terada, K.; Sakai, M.; Kawabe, Y.; Fukuda, T. Interferon-alpha and dexamethasone inhibit adhesion of T cells to endothelial cells and synovial cells. Clin. Exp. Immunol. 88:448-454; 1992.
55. 2 modulate T-cell receptor siganling through a cAMP-independent mechanism. Cell. Immunol. 169:117-124; 1996.
56. Errasfa, M.; Russo-Marie, F. A purified lipocortin shares the anti-inflammatory effect of glucocorticosteroids in vivo in mice. Br. J. Pharmacol. 97:1051-1058; 1989.
57. Falus, A.; Taga, T.; Hibi, M.; Murakami, M.; Kishimoto, T. Regulation of IL-6 receptor and gp130 expression on human cell lines of lymphoid and myeloid origin. Cytokine 4:495-499; 1992.
58. Fattal-German, M.; Ladurie, F.L.; Cerrina, J.; Lecerf, F.; Berrih,-Aknin, S. Modulation of ICAM-1 expression in human alveolar macrophages in vitro. Eur. Respir. J. 9:463-471; 1996.
59. Fernandez-Ruiz, E.; Rebollo, A.; Nieto, M.A.; Sanz, E.; Somoza, C.; Ramirez, F.; Lopez-Rivas, A.; Silva, A. IL-2 protects T cell hybrids from the cytolytic effect of glucocorticoids: Synergistic effect of IL-2 and dexamethasone in the induction of the high-affinity IL-2 receptors. J. Immunol. 143:4146-4151; 1989.
60. Fleshner, M.; Brennan, F.X.; Nguyen, K.; Watkins, L.R.; Maier, S.F. RU-486 blocks differentially suppressive effect of stress on in vivo anti-KLH immunoglobulin response. Am. J. Physiol. 271:R1344-R1352; 1996.
61. Fruman, D.A.; Klee, C.B.; Bierer, B.E.; Burakoff, S.J. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK506 and cyclosporin A. Proc. Natl. Acad. Sci. USA 89:3686-3690; 1992.
62. Garcia, K.; Scott, C.; Brunmark, A.; Carbone, F.; Peterson, P.; Wilson, I.; Teyton, L. CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes. Nature 384:577-581; 1996.
63. Garlatti, M.; Daheshia, M.; Slater, E.; Bouguet, J.; Hanoune, J.; Beato, M.; Barouki, R. A functional glucocorticoid-responsive unit composed of two overlapping inactive receptor-binding sites: Evidence for formation of a receptor tetramer. Mol. Cell. Biol. 14:8007-8017; 1994.
64. Garneli-Piperno, A.; Nolan, P.; Inaba, K.; Steinmn, R.M. The effect of immunosuppressive agents on the induction of nuclear factors that bind to sites on the interleukin 2 promoter. J. Exp. Med. 172:1869-1872; 1990.
65. Germaine, R.N. MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation. Cell 76:287-299; 1994.
66. Gessani, S.; McCandless, S.; Baglioni, C. The glucocorticoid dexamethasone inhibits synthesis of interferon by decreasing the level of its mRNA. J. Biol. Chem. 263: 7454-7457; 1938.
67. Gilbert, R.S.; Reddy, S.T.; Kujubu, D.; Xie, W.; Luner, S.; Herschman, H. Transforming growth factor beta 1 augments mitogen-induced prostaglandin synthesis and expression of the TIS10/prostaglandin synthase 2 gene both in Swiss 3T3 and in embryo fibroblasts. J. Cell Physiol. 159:647-675; 1994.
68. Goswami, R.; Lacson, R.; Yang, E.; Sam, R.; Unterman, T. Functional analysis of glucocorticoid and insulin response sequences in the rat insulin-like growth factor-binding protein-1 promoter. Endocrinology 134:736-743; 1994.
69. Gottschall, P.E.; Koves, K.; Mizuno, K.; Tatsuno, I.; Arimura, A. Glucocorticoid upregulation of interleukin 1 receptor expression in a glioblastoma cell line. Am. J. Physiol. 261:E362-E368; 1991.
70. Guida, L.; O'Hehir, R.E.; Hawrylowicz, C.M. Synergy between dexamethasone and interleukin-5 for the induction of major histocompatibility complex class II expression by human peripheral blood eosinophils. Blood 84: 2735-2740; 1994.
71. Gundel, R.H.; Wegner, C.D.; Torcellini, C.A,; Letts, L.G. The role of intercellular adhesion molecule-1 in chronic airway inflammation. Clin. Exp. Allergy 22:569-575; 1992.
72. Hamilton, J.A.; Whitty, G.A.; Royston, A.K.; Cebon, J.; Layton, J.E. Interleukin-4 suppresses granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in stimulated human monocytes. Immunology 76:566-571; 1992.
73. Hampl, J.; Chien, T.-H.; David, M.M. CD4 augments the response of a T cell to agonist but not to antagonist ligands. Immunity 7:379-385; 1997.
74. Harding, S.M.; Freedman, S.A. A comparison of oral and inhaled steroids in patients with chronic airway obstruction: Features determining response. Thorax 33:214-218; 1978.
75. Hawrylowicz, C.M.; Guida, L.; Paleolog, E. Dexamethasone upregulates granulocyte-macrophage colony-stimulating factor receptor expression on human monocytes. Immunology 83:274-280; 1994.
76. Haynes, A.R.; Shaw, R.J. Dexamethasone-induced increase in platelet-derived growth factor (B) mRNA in human alveolar macrophages and myelomonocytic HL60 macrophage-like cells. Am. J. Resp. Cell. Mol. Biol. 7:1948-206; 1992.
77. Haynesworth, S.E.; Baber, M.A.; Caplan, A.I. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: Effects of dexamethasone and IL-1α. J. Cell. Physiol. 166:585-592; 1996.
78. Her, E.; Reiss, N.; Braquet, P.; Zor, U. Characterization of glucocorticoid inhibition of antigen-induced inositolphosphate formation by rat basophilic leukemia cells: Possible involvement of phosphatases. Biochim. Biophys. Acta 1133:63-72; 1991.
79. Hess, D.C.; Bhutwala, T.; Sheppard, J.C.; Zhao, W.; Smith, J. ICAM-1 expression on human brain microvascular endothelial cells. Neurosci. Lett. 168:201-204; 1994.
80. Houssiau, F.A.; Coulie, P.G.; Van Snick, J. Distinct roles for Il-1 and IL-6 in human T cell activation. J. Immunol. 143:2520-2524; 1989.
81. Hricik, D.E.; Almawi, W.Y.; Strom, T.B. Trends in the use of glucocorticoids in renal transplantation. Transplantation 57:979-989; 1994.
82. Iseki, R.; Mukai, M.; Iwata, M. Regulation of T lymphocyte apoptosis: Signals for the antagonism between activation- and glucocorticoid-induced death. J. Immunol. 147:4286-4292; 1991.
83. Janeway, C.A. The T cell receptor as a multicomponent signaling machine: CD4/CD8 coreceptors and CD45 in T cell activation. Annu. Rev. Immunol. 10:645-674; 1992.
84. Jevnikar, A.M.; Singer, G.G.; Brennan, D.C.; Xu, H.-W.; Rubin-Kelley, V. Dexamethasone prevents autoimmune nephritis and reduces renal expression of Ia but but costimulatory signals. Am. J. Pathol. 141:743-751; 1992.
85. Johnson, B.H.; Gomi, M.; Jakowlew, S.B.; Moriwaki, K.; Thompson, E.B. Actions and interactions of glucocorticoids and transforming growth factor beta on two related human myeloma cell lines. Cell. Growth Diff. 4:25-30; 1993.
86. Johnsson, N.; Weber, K. Alkylation of cysteine 82 of p11 abolishes the complex formation with the tyrosine-protein kinase substrate p36 (annexin-2, calpactin 1, lipocortin 2). J. Biol. Chem. 265:14464-14468; 1990.
87. Jonat, C; Rahmsdorf, H.J.; Park, K.-K.; Cato, A.C.B.; Gebel, S.; Ponta, H.; Herrlich, P. Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/ Jun) activity by glucocorticoid hormone. Cell 62:1189-1204; 1990.
88. June, C.H.; Ledbetter, J.A.; Linsley, P.S.; Thompson, C.B. Role of the CD28 receptor in T cell activation. Immunol. Today 11:211-216; 1990.
89. Jungman, R.A.; Wang, X.-S.; Milkowski, D.M.; Short, M.L. Glucocorticoid induction of CRE-binding protein isoform mRNA in rat C6 glioma cells. Nucleic Acids Res. 20:825-829; 1992.
90. Kern, J.A.; Lamb, R.; Reed, J.; Daniele, R.; Nowell, P.C. Dexamethasone inhibition of interleukin 1 beta production by human monocytes: Posttranscriptional mechanisms. J. Clin. Invest. 81:237-244; 1988.
91. Klausner, R.D.; Samelson, L.E. T cell antigen receptor activation pathways: The tyrosine kinase connection. Cell 64:857-878; 1991.
92. Knudsen, P.J.; Dinarello, C.A.; Strom, T.B. Glucocortiocids inhibit transcription and post-transcriptional expression of interleukin-1. J. Immunol. 139:4129-4134; 1987.
93. Krouwels, F.H.; van der Heijden, J.F.; Lutter, R.; van Neerven, R.J.; Jansen, H.M.; Out, T.A. Glucocorticosteroids affect functions of airway- and blood-derived human T cell clones, favoring the Th1 profile through two mechanisms. Am. J. Respir. Cell. Mol. Biol. 14:388-397; 1996.
94. Kubin, M.; Chow, J.M.; Trinchieri, G. Differential regulaation of interleukin-12 (IL-12), tumor necrosis factor alpha, and IL-1 beta production in human myeloid leukemia cell lines and peripheral blood mononuclear cells. Blood 83:1847-1855; 1994.
95. Kundig, T.M.; Shahinian, A.; Kawai, K.; Mittrucker, H.W.; Sebzda, E.; Bachmann, M.F.; Mak, T.W.; Ohashi, P.S. Duration of TCR Stimulation determines co-stimulatory requirements of T cells. Immunity 5:41-52, 1996.
96. Kunicka, J.F.; Talle, M.A.; Denhardt, G.H.; Brown, M.; Prince, L.A.; Goldstein, G. Immunosuppression by glucocorticoids: Inhibition of production of multiple lymphokines by in vivo administration of dexamethasone. Cell. Immunol. 149:39-49; 1993.
97. Kutteh, W.H.; Rainey, W.E.; Carr, B.R. Glucocorticoids inhibit lipopolysaccharide-induced production of tumor necrosis factor-α by human fetal Kuppfer cells. J. Clin. Endocrinol. Metabol. 73:296-301.
98. Kwon, O.J.; Au, B.T.; Collins, P.D.; Baraniuk, J.N.; Adcock, I.M.; Chung, K.F.; Barnes, P.J. Inhibition of interleukin-8 expression by dexamethasone in human cultured airway epithelial cells. Immunology 81:389-394; 1994.
99. Lamas, M.; Sanz, E.; Martin-Parras, L.; Espel, E.; Sperisen, P.; Collins, M.; Silva, A.G. Glucocorticoid hormones upregulate interleukin-2 receptor alpha gene expression. Cell. Immunol. 151:437-450; 1993.
100. La Salle, J.M.; Haffler, D.A. T cell anergy. FASEB J. 8:601-604; 1994.
101. Lee, S.W.; Tsuo, A.-P.; Chan, H.; Thomas, J.; Petrie, K.; Eugui, E.M.; Allison, A.C. Glucocorticoids selectively inhibit the transcription of the interleukin 1β gene and decrease the stability of interleukin 1β mRNA. Proc. Natl. Acad. Sci. USA 85:1204-1208; 1988.
102. Leung, D.Y.; Martin, R.J.; Szefler, S.J.; Sher, E.R.; Ying, S.; Kay, A.B.; Hamid, Q. Dysregulation of interleukin-4, interleukin-5, and intereron-ã gene expression in steroid-resistant asthma. J. Exp. Med. 181:33-40; 1995.
103. Linsley, P.S.; Brady, W.; Urnes, M.; Grosmaire, L.S.; Damle, N.K.; Ledbetter, J.A. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174:561-569; 1991.
104. Liscovitch, M. Crosstalk among multiple signal-activated phospholipases. Trends Biochem. Sci. 17:393-399; 1992.
105. Macchioni, P.; Bolardi, L.; Meliconi, R.; Salvarani, C.; Grazia-Uguccioni, M.; Rossi, F.; Pulsatelli, L.; Facchini, A. Elevated soluble intercellular adhesion molecule 1 in the serum of patients with polymyalgia rheumatica: Influence of steroid treatment. J. Rheumatol. 21:1860-1864; 1994.
106. Madden, D.R. The three dimensional structure of peptide-MHC complexes. Annu. Rev. Immunol. 13:587-622; 1995.
107. Maier, B.; Buhring, H.J.; Simon, M.; Eichman, K.; Melchers, I. Limiting dilution analysis of proliferation and helper T cells in the in vivo immune response to KLH: Depression of helper T class at moderately increased frequencies. J. Mol. Cell. Immunol. 2:293-305; 1986.
108. Majerus, P.W.; Ross, T.S.; Cunningham, T.W.; Caldwell, K.K.; Bennett, K.; Jefferson, A.; Bansal, V.S. Recent insights into phosphatidyl inositol signaling. Cell 63: 459-465; 1990.
109. Mancuso, F.; Flower, R.J.; Perretti, M. Leukocyte transmigration, but not rolling or adhesion, is selectively inhibited by dexamethasone in the hamster post-capillary venule. Involvement of endogenous lipocortin. J. Immunol. 155:377-386; 1995.
110. Manger, B.; Weiss, A.; Imboden, J.; Laing, T.; Stobo, J.D. The role of protein kinase C in transmembrane signaling by the T cell antigen receptor complex. Effect of stimulation with soluble or immobilized CD3 antibodies. J. Immunol. 139:2755-2760; 1987.
111. - generation by dexamethasone is mimicked by lipocortin I in alveolar macrophages. J. Clin. Invest. 83:1936-1940; 1989.
112. Maroder, M.; Martinotti, S.; Vacca, A.; Scrrepanti, I.; Petrangeli, E.; Frati, L.; Gulino, A. Post-transcriptional control of c-myc proto-oncogene expression by glucocorticoids in human T lymphoblastic leukemic cells. Nucleic Acids Res. 18:1153-1157; 1990.
113. McKenzie, D. Alloantigen presentation by B cells. Requirement for IL-1 and IL-6. J. Immunol. 141:2907-2911; 1988.
114. McLeod, J.D.; Bolton, C. Dexamethasone induces an increase in intracellular and membrane-associated lipocortin-1 (annexin-1) in rat astrocyte primary cultures. Cell. Mol. Neurobiol. 15:193-205; 1995.
115. Mehindate, K.; al-Daccak, R.; Rink, L.; Mecheri, S.; Hebert, J.; Mourad, W. Modulation of mycoplasma arthritidis-derived superantigen-induced cytokine gene expression by dexamethasone and interleukin-4. Infect. Immun. 62:4716-4721; 1994.
116. Meisler, N.; Keefer, K.A.; Ehrlich, H.P.; Yager, D.R.; Myers-Perrelli, J.; Cutroneo, K.R. Dexamethasone abrogates the fibrogenic effect of transforming growth factor-beta in rat granuloma and granulation tissue fibroblasts. J. Invest. Dermatol. 108:285-289; 1997.
117. Miesfield, R.L. Molecular genetics of corticosteroid action. Am. Rev. Resp. Dis. 141:S11-S17; 1990.
118. Migliorati, G.; Nicoletti, I.; Pagliacci, M.C.; D'Adamio, L.; Riccardi, C. Interleukin-4 protects double negative and CD4 single positive thymocytes from dexamethasone-induced apoptosis. Blood 81:1352-1358; 1993.
119. Minami, Y.; Kono, T.; Miyazaki, T.; Taniguchi, T. The IL-2 receptor complex: Its structure, function, and target genes. Annu. Rev. Immunol. 11:245-268; 1993.
120. Mizutani, H.; May, L.T.; Sehgal, P.B.; Kupper, T.S. Synergistic interactions of IL-1 and IL-6 in T cell activation. J. Immunol. 143:896-901; 1989.
121. Moffat, P.; Plaa, G.L.; Denizeau, F. Induction of metallothionein gene expression by epidermal growth factor and its inhibition by transforming growth factor-beta and dexamethasone in rat hepatocytes. Hepatology 21:1038-1044; 1995.
122. Monfar, M.; Blenis, J. Inhibition of p70/p85 S6 kinase activities in T cells by dexamethasone. Mol. Endocrinol. 10:1107-1115; 1996.
123. Monick, M.M.; Aksamit, T.R.; Geist, L.J.; Hunninghake, G.W. Dexamethasone inhibits IL-1 and TNF activity in human lung fibroblasts witthout affecting IL-1 or TNF receptors. Am. J. Physiol. 2647:L33-L38; 1994.
124. Mor, F.; Cohen, I.R. IL-2 rescues antigen-specific T cells from radiation or dexamethasone-induced apoptosis. Correlation with induction of Bcl-2. J. Immunol. 156:515-522; 1996.
125. Mordacq, J.C.; Linzer, D.I.H. Co-localization of elements required for phorbol ester stimulation and glucocorticoid repression of proliferin gene expression. Genes Dev. 3:760-769; 1989.
126. Mon, A.; Kaminuma, O.; Suko, M.; Inoue, S.; Ohmura, T.; Hoshino, A.; Asakura, Y.; Miyazawa, K.; Yokota, T.; Okumura, Y.; Ito, K.; Okudaira, H. Two distinct pathways of interleukin-5 synthesis in allergen-specific human T-cell clones are suppressed by glucocorticoids. Blood 89:2891-2900; 1997.
127. Moynihan, J.A.; Karp, J.D.; Cohen, N.; Cocke, R. Alterations in interleukin-4 and antibody production following pheromone exposure: Role of glucocorticoids. J. Neuroimmunol. 54:51-58; 1994.
128. Mukaida, N.; Gussella, G.L.; Kasahara, T.; Ko, Y.; Zachariae, C.O.C.; Kawai, T. Molecular analysis of the inhibition of interleukin-8 production by dexamethasone in a human fibrosarcoma cell line. Immunology 75:674-679; 1992.
129. Mukaida, N.; Zachariae, C.C.; Gusella, G.L.; Matsushima, K. Dexamethasone inhibits the induction of monocyte chemotactic-activating factor production by IL-1 or tumor necrosis factor. J. Immunol. 146:1212-1215; 1991.
130. Naseer, T.; Minshall, E.M.; Leung, D.Y.; Laberge, S.; Ernst, P.; Martin, R.J.; Hamid, Q. Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am. J. Resp. Crit. Care Med. 155:845-851; 1997.
131. Nieto, M.A.; Lopez-Rivas, A. Interleukin-2 protects T lymphocytes from glucocorticoid-induced DNA fragmentation and cell death. J. Immunol. 143:4166-4170; 1989.
132. Northrop, J.P.; Crabtree, G.R.; Mattila, P.S. Negative regulation of interleukin 2 transcription by the glucocorticoid receptor. J. Exp. Med. 175:1235-1245; 1992.
133. Novelli, F.; DiPierro, F.; diCelle, P.F.; Bertini, S.; Affaticati, P.; Garotta, G.; Forni, G. Environmental signals influencing expression of the IFN-γ receptor on human T cells control whether IFN-γ promotes proliferation or apoptosis. J. Immunol. 152:496-504; 1994.
134. Okayama, H.; Fushimi, T.; Shimura, S.; Sasaki, H.; Shirato, K. Glucocorticoids suppressed production and gene expression of interleukin-5 by peripheral blood mononuclear cells in atopic patients and normal subjects. J. Allergy Clin. Immunol. 93:1006-1012; 1994.
135. Orosz, C.G. Endothelial activation and chronic allograft rejection. Clin. Transplant. 8:299-303; 1994.
136. Oursler, M.J.; Riggs, B.L.; Speisberg, T.C. Glucocorticoid-induced activation of latent transforming growth factor-beta by normal human osteoblast-like cells. Endocrinology 133:2187-2196; 1993.
137. Paliogianni, F.; Ahuja, S.S.; Balow, J.P.; Balow, J.E.; Booumpas, D.T. Novel mechanism for inhibition of human T cells by glucocorticoids. Glucocorticoids inhibit signal transduction through the IL-2 receptor. J. Immunol, 151:4081-40849; 1993.
138. Paliogianni, F.; Boumpas, D.T. Glucocortcoids regulate calcineurin-dependent trans-activating pathways for interleukin-2 gene transcription in human T lymphocytes. Transplantation 59:1333-1339; 1995.
139. Paliogianni, F.; Raptis, A.; Ahuja, S.S.; Najjar, S.M.; Booumpas, D.T. Negative regulation of human interleukin 2 (IL-2) gene by glucocorticoidss through interference with nuclear transcription factors AP-1 and NF-AT. J. Clin. Invest. 91:1481-1489; 1993.
140. Pankewycz, O.; Kelley, V.E.; Strom, T.B. The cascading effects of IL-1, Il-6, and IL-2 in T cell proliferation. Clin. Immunol. Immunopathol. 55:647-658; 1990.
141. Pawson, T. Protein modules and signalling networks. Nature 373:573-580; 1995.
142. Perrella, M.A.; Yoshizumi, M.; Fen, Z.; Tsai, J.C.; Hsieh, C.M.; Kourembanas, S.; Lee, M.E. Transforming growth factor-beta 1, but not dexamethasone, down-regulates nitric oxide synthase mRNA after its induction by interleukin-1 beta in rat smooth muscle cells. J. Biol. Chem. 269:14595-14600; 1994.
143. Perretti, M.; Flower, R.J. Modulation of IL-1-induced neutrophil migration by dexamethasone and lipocortin 1. J. Immunol. 150:992-999; 1993.
144. Pietzko, D.; Zohlhofer, D.; Graeve, L.; Fleischer, D.; Stoyan, T.; Schooltnik, H.; Rose-John, S.; Heinrich, P.C. The hepatic interleukin-6 receptor. Studies on its structure and regulation by phorbol 12-myristate 13-acetate-dexamethasone. J. Biol. Chem. 268:4250-4258; 1993.
145. Pitzalis, C.; Pipitone, N.; Bajocchi, G.; Hall, M.; Goulding, N.; Lee, A.; Kingsley, G.; Lanchbury, J.; Panayi, G. Corticosteroids inhibit lymphocyte binding to endothelium and intercellular adhesion. An additional mechanism for their anti-inflammatory and immunosuppressive effect. J. Immunol. 158:5007-5016; 1997.
146. Potchinsky, M.; Nugent, P.; Lafferty, C.; Greene, R.M. Effect of dexamethasone on the expression of transforming growth factor-β in mouse embryonic palatal mesenchymal cells. J. Cell. Physiol. 166:380-386; 1996.
147. Ramirez, F.; Fowell, D.; Puklavec, M.; Simmonds, S.; Mason, D. Glucocorticoids promote a Th2 cytokine response by CD4+ T cells in vitro. J. Immunol. 156: 2406-2412; 1996.
148. Ray, A.; LaForge, K.S.; Sehgal, P.B. On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: Enhancer, TAT box, and RNA start site (Inr motif) occlusion. Mol. Cell. Biol. 10:5736-5746; 1990.
149. Ray, A.; Sehgal, P.B. Cytokines and their receptors: Molecular mechanism of interleukin-6 gene repression by glucocorticoids. J. Am. Soc. Nephrol. 2:S214-S221; 1992.
150. Re, F.; Muzio, M.; De Rossi, M.; Polentaruti, N.; Giri, J.G.; Mantovani, A.; Colotta, F. The type II "Receptor" as a decoy target for interleukin 1 in polymorphonuclear leukocytes: Characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor. J. Exp. Med. 179:739-743; 1994.
151. Redondo, J.M.; Fresno, M.; Lopez-Rivas, A. Inhibition of interleukin 2-induced proliferation of cloned murine T cells by glucocorticoids. Possible involvement of an inhibitory protein. Eur. J. Immunol. 18:1555-1559; 1988.
152. Reyes-Moreno, C.; Frenette, G.; Boulanger, J.; Lavergne, E.; Govindan, M.V.; Koutsilieris, M. Mediation of glucocorticoid receptor function by transforming growth factor beta 1 expression in human PC-3 prostate cancer cells. Prostate 26:260-269; 1995.
153. Rolfe, F.G.; Hughes, J.M.; Armour, C.L.; Sewell, W.A. Inhibition of interleukin-5 gene expression by dexamethasone. Immunology 77:494-499; 1992.
154. Rudd, R. Corticosteroids in chronic bronchitis. Br. Med. J. 288:1553-1554; 1984.
155. Sadeghi, R.; Feldmann, M.; Hawrylowicz, C. Upregulation of HLA class II, but not intercellular adhesion molecule 1 (ICAM-1) by granulocyte-macrophage colony stimulating factor (GM-CSF) or interleukin-3 (IL-3) in synergy with dexamethasone. Eur. Cytokine Netw. 3:373-380; 1992.
156. Sapi, E.; Flick, M.; Gilmore-Hebert, M.; Rodov, S.; Kacinski, B. Transcriptional regulation of the c-fms (CSF-1R) proto-oncogene in human breast carcinoma cells by glucocorticoids. Oncogene 10:529-542; 1995.
157. Schmidt, J.; Fleissner, S.; Heimann-Weitschat, I.; Lindstaedt, R.; Pomberg, B.; Werner, U.; Szelenyi, I. Effect of corticosteroids, cyclosporin A, and methotrexate on cytokine release from monocytes and T cell subsets. Immunopharmacology 27:173-179; 1994.
158. Schooltnik, H.; Schmitz van der Leur, H.; Heinrich, P.C.; Rose-John, S. Upregulation of interleukin-6 signal transducing protein (gp130) by interleukin-6 and dexamethasone in HepG2 cells. FEBS Lett. 297:263-265; 1992.
159. Schwartz, R.H. Models of T cell anergy: Is there a common molecular mechanism? J. Exp. Med. 184:1-8; 1996.
160. Shieh, J.-H.; Peterson, R.H.F.; Moore, M.A.S. Bacterial endotoxin regulation of cytokine receptors on murine bone marrow cells: In vivo and intro study. J. Immunol. 152:859-866; 1994.
161. Sierra-Honigmann, M.R.; Murphy, P.A. T cell receptor-independent immunosuppression induced by dexamethasone in murine T helper cells. J. Clin. Invest. 89:556-560; 1992.
162. Skouteris, G.G.; Schroder, C.H. The hepatocyte growth factor receptor kinase-mediated phosphorylation of lipocortin-1 transduces the proliferating signal of the hepatocyte growth factor. J. Biol. Chem. 271:27266-27273; 1996.
163. Slavin, J.; Unemori, E.; Hunt, T.K.; Amento, E. Transforming growth factor beta (TGF-beta) and dexamethasone have direct opposing effects on collagen metabolism in low passage human dermal fibroblasts in vitro. Growth Factors 11:205-213; 1994.
164. Snyers, L.; De Wit, L.; Content, J. Glucocorticoid upregulation of high-affinity interleukin 6 receptors on human epithelial cells. Proc. Natl. Acad. Sci. USA 87: 2838-2842; 1990.
165. Sollinger, H.W. (for the U.S. Renal Transplant Mycophenolate Mofetil study Group). Mycophenolate mofetil for the prevention of acute rejection in parimary cadaveric renal allograft recipients. Transplantation 60:225-232; 1995.
166. Spriggs, M.K.; Lioubin, P.J.; Slack, J.; Dower, S.K.; Jonas, U.; Cosman, D.; Sims, J.E.; Bauer, J. Induction of an interleukin-1 receptor (IL-1R) on monocytic cells. Evidence that the receptor is not encoded by a T cell-type IL-1R mRNA. J. Biol. Chem. 265:22499-22505; 1990.
167. Strickland, R.W.; Wahl, L.M.; Finbloom, D.S. Corticosteroids enhance the binding of recombinant interferon-γ to cultured human monocytes. J. Immunol. 137:1577-1580; 1986.
168. Sudlow, A.W.; Carey, F.; Forder, R.; Rothwell, N.J. The role of lipocortin-1 in dexamethasone-induced suppression of PGE2 and TNF alpha release from human peripheral blood mononuclear cells. Br. J. Pharmacol. 117:1449-1456; 1996.
169. Suh, D.S.; Ooi, G.T.; Rechler, M.M. Identification of cis-elements mediating the stimulation of rat insulin-like growth factor-binding protein-1 promoter activity by dexamethasone, cyclic adenosine 3′,5′-monophosphate, and phorbol esters, and inhibition by insulin. Mol. Endocrinol. 8:794-805; 1994.
170. Suthanthiran, M. A novel model for antigen-dependent activation of normal human T cells. Transmembrane signalling by cross-linkage of the CD3/T cell receptor α/β complex with the cluster determinant 2 antigen. J. Exp. Med. 171:1965-1979; 1990.
171. Suthanthiran, M.; Strom, T.B. Immunobiology and immunopharmacology of organ allograft rejection. J. Clin. Immunol. 15:161-171; 1995.
172. Taylor, A.D.; Cowell, A.M.; Flower, R.J.; Buckingham, J.C. Dexamethasone suppresses the release of prolactin from the rat anterior pituitary gland by lipocortin dependent and independent mechanisms. Neuroendocrinology 62:530-542; 1996.
173. Tessier, P.; Audette, M.; Cattaruzzi, P.; McColl, S.R. Upregulation by tumor necrosis factor-á of intracellular adhesion molecule-1 expression and function in synovial fibroblasts and its inhibition by glucocorticoids. Arthritis Rheum. 11:1528-1539; 1993.
174. Thompson, C.B.; Lindsten, T.; Ledbetter, J.A.; Kunkel, S.L.; Young, H.A.; Emerson, S.; Leiden, J.; June, C.H. CD28 activation pathway regulates the production of multiple T cell derived lymphokines/cytokines. Proc. Natl. Acad. Sci. USA 86:1333-1337; 1989.
175. Tobena, R.; Horikawa, S.; Calvo, V.; Alemany, S. Interleukin-2 induces -γ-S-adenosyl-L-methionine synthetase gene expression during T-lymphocyte activation. Biochem. J. 319:929-933; 1996.
176. Tobler, A.; Meier, R.; Seitz, M.; Dewald, B.; Baggiolini, M.; Fey, M.F. Glucocorticoids downregulate gene expression of GM-CSF-NAP-1/IL-8, and IL-6, but not M-CSF, in human fibroblasts. Blood 79:45-51; 1992.
177. Tosato, G.; Miller, J.; Marti, G.; Pike, S. Accessory function of interleukin-1 and interleukin-6: Preferential co-stimulation of T4 positive lymphocytes. Blood 75: 922-930; 1990.
178. Vacca, A.; Felli, M.P.; Farina, A.R.; Martinotti, S.; Maroder, M.; Screpanti, I.; Meco, D.; Petrangeli, E.; Frati, L.; Gulino, A. Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity netween nuclear factor of activated T cells and AP-1 enhancer elements. J. Exp. Med. 175:637-646; 1992.
179. Vacca, A.; Martinotti, S.; Screpanti, I.; Maroder, M.; Felli, M.P.; Farina, A.R.; Gismondi, A.; Santoni, A.; Frati, L.; Gulino, A. Transcriptional regulation of the interleukin 2 gene by glucocorticoid hormones. Role of steroid receptor and antigen-responsive 5′-flanking sequences. J. Biol. Chem. 265:8075-8080; 1990.
180. van de Stolpe, A.; Caldenhoven, E.; Raaijmakers, J.A.; van der Saag, P.T.; Koenderman, L. Glucocorticoid-mediated repression of intercellular adhesion molecule-1 expression in human moncytic and bronchial epithelial cell lines. Am. J. Respir. Cell. Mol. Biol. 8:340-347; 1993.
181. Violette, S.M.; King, I.; Browning, J.L.; Pepinsky, R.B.; Wallner, B.P.; Sartorelli, A. Role of lipocortin I in the glucocorticoid induction of the terminal differentiation of a human squamous carcinoma. J. Cell. Physiol. 142:70-77; 1990.
182. Waldmann, T.A. The interleukin-2 receptor. J. Biol. Chem. 266:2681-2684; 1991.
183. Wallemacq, P.E.; Reding, R. FK506 (tacrolimus), a novel immuno-suppressant in organ transplantation: Clinical, biomedical, and analytical aspects. Clin. Chem. 39:2219-2228; 1993.
184. Wallner, B.P.; Mattaliano, R.J.; Hession, C.; Cate, R.L.; Tizard, R.; Sinclair, L.K.; Foeller, C.; Chow, E.P.; Browning, J.L.; Ramachandran, K.L.; Pepinsky, R.B. Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity. Nature 320:77-81; 1986.
185. Wang, Y.; Campbell, H.D.; Young, I.G. Sex hormones and dexamethasone modulate interleukin-5 gene expression in T lymphocytes. J. Steroid Biochem. Mol. Biol. 44:203-210; 1993.
186. Wang, J.; Kuliszewski, M.; Yee, W.; Sedlackova, L.; Xu, J.; Tseu, I.; Post, M. Cloning and expression of glucocorticoid-induced genes in fetal rat lung fibroblasts. Transforming growth factor-beta 3. J. Biol. Chem. 270:2722-2728; 1995.
187. Wange, R.L.; Samelson, L.E. Complex complexes: Signaling at the TCR. Immunity 5:197-205; 1996.
188. Webb, D.S.; Roth, J.A. Relationship of glucocorticoid suppression of arachidonic acid metabolism to alteration of neutrophil function. J. Leukocyte Biol. 41:156-164; 1987.
189. Webster, E.L.; Elenkov, I.J.; Chrousos, G.P. The role of corticotropin-releasing hormone in neuroendocrine-immune interactions. Mol. Psychiatry 2:368-372; 1997.
190. Weiss, A. T cell antigen receptor signal transduction: A tale of tails and cytoplasmic protein tyrosine kinases. Cell 73:209-214; 1993.
191. Williamson, R.A.; Yea, C.; Robson, P.A.; Curnock, A.P.; Gadher, S.; Hambelton, A.; Woodward, K.; Bruneay, J.; Morand, P.; Courtin, O.; Sautes, C.; Westood, R.; Hercend, T.; Kuo, E.; Ruth, E. Dihydroorotate dehydrogenase is a high affinity binding protein for A77 1726 and a mediator of a range of biological effects of the immunomodulatory compound. J. Biol. Chem. 270:22467-22472; 1995.
192. Woo, J.; Lemster, B.; Tamura, K.; Starzl, T.E.; Thompson, A.W. The anti-lymphocyte activity of brequinar sodium and its potentiation by cytidine. Effects on lymphocyte proliferation and cytokine production. Transplantation 56:374-381; 1993.
193. Wuthrich, R.P.; Sekar, P. Effect of dexamethasone, 6-mercaptopurine and cyclosporine A on intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression. Biochem. Pharmacol. 46:1349-1353; 1993.
194. Yang-Yen, H.-F.; Chambrand, J.-C.; Sun, Y.-L.; Smeal, T.; Schmidt, T.J.; Drouin, J.; Karin, M. Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62:1205-1215; 1990.
195. Yasuda, M.; Kokubu, F.; Izumi, H.; Matsukura, S.; Tokunaga, H.; Yamamoto, T.; Kuroiwa, Y.; Adachi, M. Effect of dexamethasone on intercellular adhesion molecule-1 expression on cultured bronchial epithelial cells stimulated by inflammatory cytokines. Arerugi 44:100-103; 1995.
196. Zanker, B.; Walz, G.; Wieder, K.J.; Strom, T.B. Evidence that glucocorticosteroids block expression of the human interleukin-6 gene by accessory cells. Transplantation 49:198-201; 1990.
197. Zhang, H.; Horwitz, L.; Ruvolo, P.; Colombani, P.; Hess, A.D. The role of cyclosporine-induced autoreactive T lymphocytes in solid organ allograft survival and chronic rejection. Transplantation 60:115-122; 1995.
198. Zitnik, R.J.; Whiting, N.L.; Elias, J.A. Glucocortiocoid inhibition of interleukin-1-induced interleukin-6 production by human lung fibroblasts: Evidence for transcriptional and post-transcriptional regulatory mechanisms. Am. J. Resp. Mol. Biol. 10:643-650; 1994.
199. Zubiaga, A.M.; Munoz, E.; Huber, B.T. Interleukin (IL)-4 and IL-2 rescue Th cell subsets from glucocorticoid-induced apoptosis. J. Immunol. 149:107-112; 1992.